- ￥2890
- LSM Bio
- 参照说明书
- 0.31-20ng/ml
- 国产
- ELI-10935h
- 2025年07月16日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
50
- 供应商：
LSMBIO
- 检测范围：
参照说明书
- 检测方法：
夹心法/竞争法
- 应用：
0.1ng/ml
- 适应物种：
人
- 标记物：
Breast carcinoma- amplified sequence 1, BCAS1
- 样本：
人血清、血浆或其它相关生物液体中天然和重组蛋白
- 灵敏度：
0.31-20ng/ml
- 规格：
96T
Human Breast carcinoma- amplified sequence 1, BCAS1 ELISA KIT
Product Name:Human Breast carcinoma- amplified sequence 1, BCAS1 ELISA KIT
Packing:96T
Catalog No.:ELI-10935h
Gene Name:BCAS1
Detect Range:0.312-20 ng/mL
Sensitivity:0.039ng/mL
Target Protein Name:Breast carcinoma-amplified sequence 1(BCAS1
Alternative Name:BCAS1,Breast carcinoma-amplified sequence 1(BCAS1
Sample type:serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA type:Sandwich ELISA Kit
Product Description:Human Breast carcinoma- amplified sequence 1, BCAS1 ELISA KIT allows for the in vitro quantitative determination of Breast carcinoma-amplified sequence 1(BCAS1 concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA Test Principle:
The microtiter plate provided in Human Breast carcinoma- amplified sequence 1, BCAS1 ELISA KIT has been pre-coated with an Breast carcinoma-amplified sequence 1(BCAS1 antibody specific to Breast carcinoma-amplified sequence 1(BCAS1 .Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for Breast carcinoma-amplified sequence 1(BCAS1 and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain Breast carcinoma-amplified sequence 1(BCAS1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm.The concentration of Breast carcinoma-amplified sequence 1(BCAS1 in the samples is then determined by comparing the O.D. of the samples to the standard curve.
NOTE:FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ ENTIRE PROCEDURE!
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验的原理用于分子诊断方面：TrimGen公司的KRAS Mutation Detection Kit在96孔板里一次能实现7/8个KRAS突变位点的检测。 另外基于相同原理的技术还有PPT-ELISA。这是用来筛截短突变的，相关文章见：1，Rapid screen for truncating ATM mutations by PTT-ELISA . 2，An ELISA-based high throughput protein truncation test
5 ) or 1.5% agarose gel (GAPDH ) and quantified using ImageQuant 1.2. The 1-kbp CDH5 -specific PCR product was sequenced and shown to correspond to the expected CDH5 sequence. Luciferase assays. The human CDH5 promoter fragment (-2486 to +24) was amplified
potent transcriptional activators or repressors, respectively. These results show that the human genome encodes zinc fingers with diverse DNA-binding specificities and that these domains can be used to design sequence-specific DNA-binding proteins
技术资料暂无技术资料 索取技术资料
